Moderna, Inc. (FRA:0QF)
Germany flag Germany · Delayed Price · Currency is EUR
41.62
-0.58 (-1.37%)
At close: Feb 20, 2026

Moderna Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,8183,1096,67118,43517,675
Other Revenue
126127177828796
Revenue
1,9443,2366,84819,26318,471
Revenue Growth (YoY)
-39.93%-52.74%-64.45%4.29%2200.25%
Cost of Revenue
4,0006,0079,5388,7114,608
Gross Profit
-2,056-2,771-2,69010,55213,863
Selling, General & Admin
1,0181,1741,5491,132567
Operating Expenses
1,0181,1741,5491,132567
Operating Income
-3,074-3,945-4,2399,42013,296
Interest Expense
--24-38-29-17
Interest & Investment Income
31442542120018
Other Non Operating Income (Expenses)
-8-7-14-16-12
EBT Excluding Unusual Items
-2,768-3,551-3,8709,57513,285
Gain (Loss) on Sale of Investments
--56-72--
Pretax Income
-2,768-3,607-3,9429,57513,285
Income Tax Expense
54-467721,2131,083
Net Income
-2,822-3,561-4,7148,36212,202
Net Income to Common
-2,822-3,561-4,7148,36212,202
Net Income Growth
----31.47%-
Shares Outstanding (Basic)
389384382394403
Shares Outstanding (Diluted)
389384382416431
Shares Change (YoY)
1.30%0.52%-8.17%-3.48%13.12%
EPS (Basic)
-7.25-9.27-12.3421.2230.28
EPS (Diluted)
-7.26-9.28-12.3420.1228.29
EPS Growth
----28.88%-
Free Cash Flow
-2,065-4,055-3,8254,58113,336
Free Cash Flow Per Share
-5.31-10.56-10.0111.0130.94
Gross Margin
-105.76%-85.63%-39.28%54.78%75.05%
Operating Margin
-158.13%-121.91%-61.90%48.90%71.98%
Profit Margin
-145.17%-110.04%-68.84%43.41%66.06%
Free Cash Flow Margin
-106.22%-125.31%-55.86%23.78%72.20%
EBITDA
-2,859-3,756-3,6189,76813,528
EBITDA Margin
-147.07%-116.07%-52.83%50.71%73.24%
D&A For EBITDA
215189621348232
EBIT
-3,074-3,945-4,2399,42013,296
EBIT Margin
-158.13%-121.91%-61.90%48.90%71.98%
Effective Tax Rate
---12.67%8.15%
Revenue as Reported
1,9443,2366,84819,26318,471
Advertising Expenses
-146204121-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.